MUC5B and breast carcinoma: MUC5B and MUCL1 (also known as Small Breast Epithelial Mucin/SBEM) have both been shown to drive invasion in vitro [51–53] and are associated with poor survival and metastasis in breast cancer patients [54–56], although there are no reports on effects in ILC.